781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carc...
781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress)
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundDevelopment of immunotherapy for TETs has been challenging due to the rarity of the disease, association with paraneoplastic autoimmune disorders, and a propensity toward development of serious immune-related adverse events.1 2 The safety and efficacy of combination immunotherapy is under investigation.Transforming growth factor β (TGF-β)...
Alternative Titles
Full title
781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1f0377fcd6494f30b173aacb9799ceaa
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1f0377fcd6494f30b173aacb9799ceaa
Other Identifiers
E-ISSN
2051-1426
DOI
10.1136/jitc-2023-SITC2023.0781
